Icatibant（HOE-140）是强效且特异的缓激肽B2受体拮抗剂，其IC50值为1.07nM，Ki值为0.798nM。

[1] Bawolak MT, Fortin JP, Vogel LK, Adam A, Marceau F. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors. Eur J Pharmacol. 2006 Dec 3;551(1-3):108-11. doi: 10.1016/j.ejphar.2006.08.077. Epub 2006 Sep 8. PMID: 17026984.[2]Arai Y, Takanashi H, Kitagawa H, Wirth KJ, Okayasu I. Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice. Dig Dis Sci. 1999 Apr;44(4):845-51. doi: 10.1023/a:1026694732602. PMID: 10219847.